Latest Transplant Approaches for Myeloma

Despite its status as the standard therapy for multiple myeloma (MM), hematopoietic stem cell transplantation continues to be the source of study and consideration as new therapies for myeloma evolve. In this video, Adam D. Cohen, MD, offers his perspective on recent studies in the timing of autologous stem cell transplantation in MM and its potential role as a platform for immunotherapy, induction regimens in the pre-transplantation interim, and an assessment of the role of allogeneic transplantation.



Related Links


June 3, 2015

Created by

Penn Physician VideoLink